Nasdaq Stockholm

NextCell Pharma AB

ISIN SE0009723125Filings at the FI

At a glance

Most recent filing on June 16, 2025 — a sale by Hangethe Consulting AB on Jun 16, 2025.

We hold 28 visible filings, going back to August 23, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 28 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 28. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Hangethe Consulting AB Closely associated: Chief financial officer
221,992 SEKOpen-market buy
TradedJun 13, 2025FiledJun 16, 2025
Hangethe Consulting AB Closely associated: Chief financial officer
196,873 SEKOpen-market sale
TradedJun 16, 2025FiledJun 16, 2025
Hangethe Consulting AB Closely associated: Chief financial officer
197,678 SEKOpen-market buy
TradedJun 16, 2025FiledJun 16, 2025
Hangethe Consulting AB Closely associated: Chief financial officer
215,563 SEKOpen-market sale
TradedJun 13, 2025FiledJun 16, 2025
Mathias Svahn Chief executive officer
454,019 SEKOption exercise
TradedMay 30, 2025FiledJun 3, 2025